NAD+

Price range: $100.00 through $180.00

SKU: YPB.223 Categories: ,

Description

A single-component research material supplied for controlled research environments. Suitable for studies involving nucleotide cofactor characterization and method development in model systems.


Composition

• NAD+
Format: Synthetic
Fill Volume: 6 mL vial
Appearance: Sterile solution in a sealed research vial


Research Focus (non-clinical)

• Identity and purity assessment via HPLC/LC-MS and UV-Vis quantitation
• Assay development and calibration for enzymatic cycling or cell-free systems
• Chromatographic method optimization for impurity/degradation profiling (e.g., NADH/NADP)
• Stability characterization under laboratory storage conditions (temperature, pH, light)

For qualified research professionals and institutional laboratories. Not for human use.


Documentation & Quality Assurance

Each lot is sourced through our verified global supply chain with emphasis on traceability and quality control. We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process. These documents are reviewed internally and displayed as they become available. Independent third-party testing is also performed on select lots to confirm identity, purity, and alignment with our internal specifications.


Important Notice

This product is intended for laboratory research use only. It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes.
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S. Food and Drug Administration.


Quality & Manufacturing

All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles. Each supplier is reviewed for reliability, documentation integrity, and transparency in testing.

We require a verified purity of 99% or higher and perform independent third-party spot testing to confirm that select lots meet our internal standards for identity, purity, and composition. Where available, endotoxin testing results are included on Certificates of Analysis to verify laboratory purity; their inclusion is for research quality assessment only and does not imply suitability for human or veterinary use.

All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.

Additional information

Weight 0.2 lbs
Dosage

500mg, 1000mg

Storage Instructions

All our research peptides are manufactured using a lyophilization (freeze-drying) process. This method is designed to maintain product integrity and allows vials to remain stable during shipping for approximately 3–4 months.

Once a vial is reconstituted with bacteriostatic water, it should be stored in the refrigerator to help maintain stability. Under these conditions, reconstituted material is generally considered stable for up to 30 days.

Lyophilization is a dehydration technique in which compounds are frozen and then exposed to low pressure. This causes the water in the vial to sublimate directly from solid to gas, leaving behind a stable, crystalline white structure. This powder can be kept at room temperature until reconstitution.

Upon receipt, products should be stored away from heat and light. For short-term use, refrigeration at approximately 4°C (39°F) is suitable. For long-term storage (several months to years), vials may be placed in a freezer at approximately -80°C (-112°F). Freezing is the preferred method for preserving product stability over extended periods.

⚠️ Important Notice: These products are intended for research use only. Not for human consumption.

Certificate of Analysis

NAD+ - COA - Debs Peptalk

Research Use Only

These studies reference research-grade peptides for laboratory and scientific investigation only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Published Scientific Research

Peer-reviewed laboratory research investigating research peptides from leading scientific databases

In Vitro Study
PubMed

NAD dyshomeostasis in RYR1-related myopathies.

Skeletal muscle 2025

BACKGROUND: Pathogenic variants in RYR1 cause a spectrum of rare congenital myopathies associated with intracellular calcium dysregulation. NAD deficiency has been associated with skeletal muscle bioenergetic deficits in mitochondrial myopathy and sarcopenia.

View Full Study
In Vitro Study
PubMed

α-Ketoglutarate improves cardiac insufficiency through NAD-SIRT1 signaling-mediated mitophagy and ferroptosis in pressure overload-induced mice.

Molecular medicine (Cambridge, Mass.) 2024

However, the myocardial protective mechanism of AKG remains unclear. Metabolites of the malate-aspartate shuttle (MAS) were increased, but the TCA cycle and fatty acid metabolism pathway could be inhibited in the myocardium of TAC mice after AKG supplementation.

View Full Study
Molecular Analysis
PubMed

Substrate-induced condensation activates plant TIR domain proteins.

Nature 2024

Plant nucleotide-binding leucine-rich repeat (NLR) immune receptors with an N-terminal Toll/interleukin-1 receptor (TIR) domain mediate recognition of strain-specific pathogen effectors, typically via their C-terminal ligand-sensing domains. The mechanism underlying the activation of these TIR domain proteins remain unclear.

View Full Study
In Vitro Study
PubMed

Nampt/SIRT2/LDHA pathway-mediated lactate production regulates follicular dysplasia in polycystic ovary syndrome.

Free radical biology & medicine 2024

Furthermore, target energy metabolomics and transcriptome results showed that NMN supplementation ameliorates the lactate production by activating glycolytic process in the ovary. Overall, these benefits of NMN were elucidated and the Nampt/SIRT2/LDHA pathway mediated lactate production in granulosa cells played an important role in the improvement of follicular development disorders in PCOS.

View Full Study
Mechanism Study
PubMed

Oxidative damage and mitochondrial dysfunction in cystathionine beta-synthase deficiency.

Scientific reports 2024

Cystathionine beta-synthase deficiency (CBSD) is the most prevalent inherited disorder of homocysteine metabolism in the transsulphuration pathway. Research have suggested oxidative stress and inflammation as candidate pathogenic mechanisms in CBSD.

View Full Study
In Vitro Study
PubMed

Phase separation of FSP1 promotes ferroptosis.

Nature 2023

icFSP1-induced FSP1 condensates show droplet-like properties consistent with phase separation, an emerging and widespread mechanism to modulate biological activity.

View Full Study